1 | Experimental: Seladelpar / MBX-8025 200 mg | 1件: Seladelpar Seladelpar | 1件: D11256
D11256
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 93 93 |
2 | Experimental: Seladelpar / MBX-8025 50 mg | 1件: Seladelpar Seladelpar | 1件: D11256
D11256
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 93 93 |
3 | MBX-8025 | - | - | - | - | 3件: 79 79, 93, 94 |
4 | MBX-8025 50 mg (Dose Escalation Period 1) | - | - | - | - | 1件: 79 79 |
5 | MBX-8025 50 mg or 100 mg (Dose Escalation Period 2) | - | - | - | - | 1件: 79 79 |
6 | MBX-8025 50 mg, 100 mg or 200 mg (Dose Escalation Period 3) | - | - | - | - | 1件: 79 79 |
7 | MBX-8025, DSIC | - | - | - | - | 1件: 93 93 |
8 | MBX-8025, Formulation 2 | - | - | - | - | 1件: 93 93 |